Is compounded as effective as brand?
Same molecule; trial data applies to brand; compounded quality affects real-world result.
Could my compounded semaglutide be under-dosed?
Possible at non-licensed sources; licensed 503A with quality testing is generally accurate.
What dose is needed for weight loss?
2.4 mg weekly is the FDA-approved Wegovy maximum; compounded prescriptions often match this range.
How long until weight loss?
Initial loss within 4-6 weeks; substantial loss requires titration to therapeutic doses.
Should I increase my dose?
Discuss with prescriber; 2.4 mg is the ceiling for brand.
Why did I lose then stop?
Biological plateau pattern around week 28-40.
Could my response be biologically modest?
Yes; about 14% of STEP 1 participants lost under 5%.
Should I switch to tirzepatide?
Reasonable consideration after addressing other factors at max semaglutide dose.
What if compounded isn't working?
Verify pharmacy quality; consider transition to brand or tirzepatide if persistent.
Related guides
- How Long for Semaglutide to Work? The Pharmacology of the Molecule, Brand or Compounded
- Why Am I Not Losing Weight on Ozempic? The Six Causes Worth Investigating
- Why Am I Not Losing Weight on Mounjaro? Plateau Patterns and Real Causes
- Why Am I Not Losing Weight on Zepbound? Plateau Realities and Course Correction
- Why Am I Not Losing Weight on Wegovy? The Six Levers Worth Pulling
- Why Am I Not Losing Weight on Tirzepatide? Decoding Stalled Progress
Sources
- Wilding JPH et al., STEP 1, NEJM March 2021
- Rubino D et al., STEP 4, JAMA April 2021
- Lincoff AM et al., SELECT, NEJM November 2023
- Wegovy FDA prescribing information
- Ozempic FDA prescribing information
- Jastreboff AM et al., SURMOUNT-1, NEJM July 2022
- Tasali E et al., JAMA Internal Medicine March 2022
- USP General Chapter 797, Pharmaceutical Compounding - Sterile Preparations
- Federal Food, Drug, and Cosmetic Act Section 503A
- Endocrine Society Clinical Practice Guideline on Obesity, 2023
- American Thyroid Association screening guidelines
- National Sleep Foundation duration recommendations
Footer disclaimers
Platform Disclaimer. FormBlends connects patients with licensed clinicians for GLP-1 therapy. This article is educational. Individual situations require clinical assessment by your prescriber.
Get medications from a trusted source
FormBlends sources through 503A compounding pharmacies with third-party purity testing on every batch.
Start Free Assessment →Compounded Medication Notice. Compounded semaglutide is prepared by 503A pharmacy partners for individual patients with documented clinical justification. Not FDA-approved. STEP, STEP 4, and SELECT trial data apply to brand Wegovy and Ozempic specifically.
Results Disclaimer. Individual outcomes vary substantially. STEP 1 reported a 14.9% mean weight loss with significant variation; ~14% of participants lost under 5%. Your result depends on dose, adherence, baseline, lifestyle, and physiology.
Trademark Notice. Ozempic, Wegovy, Rybelsus, and NovoCare are trademarks or service marks of Novo Nordisk A/S. FormBlends is independent.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →